FDA Approves Blood Test Developed by Abbott, USAMMDA for Traumatic Brain Injury
The U.S. Food and Drug Administration recently approved a blood test the U.S. Army Medical Materiel Development Activity at Fort Detrick worked on with Abbott Point of Care, which can detect signs of traumatic brain injury more quickly than a previous test by UF startup Banyan Biomarkers. Banyan's biomarkers are used in the new device.
